{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:11:47Z","timestamp":1780553507404,"version":"3.54.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.drugalcdep.2015.10.023","type":"journal-article","created":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T19:40:09Z","timestamp":1446493209000},"page":"158-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system"],"prefix":"10.1016","volume":"157","author":[{"given":"Sandra A.","family":"Springer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick L.","family":"Altice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Estelle","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Di Paola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13722-015-0034-5","article-title":"Factors associated with willingness to take extended release naltrexone among injection drug users","volume":"10","author":"Ahamad","year":"2015","journal-title":"Addict. Sci. Clin. Pract."},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0140-6736(10)60829-X","article-title":"Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs","volume":"376","author":"Altice","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMsa064115","article-title":"Release from prison\u2014a high risk of death for former inmates","volume":"356","author":"Binswanger","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.drugalcdep.2015.10.023_bib0020","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1007\/s10461-013-0506-0","article-title":"Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail","volume":"17","author":"Chitsaz","year":"2013","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0025","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archpsyc.63.2.210","article-title":"Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial","volume":"63","author":"Comer","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0030","unstructured":"Connecticut Department of Correction, 2014. \u3008http:\/\/www.ct.gov\/doc\/lib\/doc\/PDF\/MonthlyStat\/Stat201407.pdf\u3009 (accessed 17.06.15)."},{"issue":"11","key":"10.1016\/j.drugalcdep.2015.10.023_bib0035","article-title":"A comparison of psychiatric diagnoses among HIV-infected prisoners receiving combination antiretroviral therapy and transitioning to the community","volume":"2","author":"Di Paola","year":"2014","journal-title":"Health Justice"},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0040","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cct.2014.09.002","article-title":"Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community","volume":"39","author":"Di Paola","year":"2014","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0045","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1749-6632.2010.05900.x","article-title":"Intramuscular extended-release naltrexone: current evidence","volume":"1216","author":"Gastfriend","year":"2011","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0050","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.drugalcdep.2005.02.009","article-title":"Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants","volume":"79","author":"Hulse","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/13556210310001602257","article-title":"A pilot study to assess the impact of naltrexone implant on accidental opiate overdose in \u2018high-risk\u2019 adolescent heroin users","volume":"8","author":"Hulse","year":"2003","journal-title":"Addict. Biol."},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0060","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsat.2009.03.002","article-title":"A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease","volume":"37","author":"Kinlock","year":"2009","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0065","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0093854807309111","article-title":"A study of methadone maintenance for male prisoners: 3-month postrelease outcomes","volume":"35","author":"Kinlock","year":"2008","journal-title":"Crim. Justice Behav."},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0070","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/j.1360-0443.2008.02345.x","article-title":"Persistence with oral naltrexone for alcohol treatment: implications for health-care utilization","volume":"103","author":"Kranzler","year":"2008","journal-title":"Addiction"},{"issue":"Suppl. 2","key":"10.1016\/j.drugalcdep.2015.10.023_bib0075","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1007\/s10461-012-0362-3","article-title":"Post-release substance abuse outcomes among HIV-infected jail detainees: results from a multisite study","volume":"17","author":"Krishnan","year":"2013","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0080","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","article-title":"Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial","volume":"377","author":"Krupitsky","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0085","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/YCO.0b013e3283386578","article-title":"Long-acting depot formulations of naltrexone for heroin dependence: a review","volume":"23","author":"Krupitsky","year":"2010","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0090","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/add.12894","article-title":"Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial","volume":"110","author":"Lee","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsat.2015.01.009","article-title":"Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment","volume":"54","author":"Levine","year":"2015","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0100","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/aje\/kwr327","article-title":"Risks of drug-related death, suicide, and homicide during the immediate post-release period among people released from New York City jails, 2001\u20132005","volume":"175","author":"Lim","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0105","series-title":"Bureau of Justice Statistics Bulletin","article-title":"HIV in Prisons, 2007\u201308","author":"Maruschak","year":"2009"},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the addiction severity index","volume":"9","author":"McLellan","year":"1992","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0115","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/S2352-3018(14)70022-0","article-title":"HIV in people reincarcerated in Connecticut prisons and jails: an observational cohort study","volume":"1","author":"Meyer","year":"2014","journal-title":"Lancet HIV"},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0120","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jamainternmed.2014.601","article-title":"Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate","volume":"174","author":"Meyer","year":"2014","journal-title":"JAMA Int. Med."},{"issue":"2","key":"10.1016\/j.drugalcdep.2015.10.023_bib0125","first-page":"CD001333","article-title":"Oral naltrexone maintenance treatment for opioid dependence","author":"Minozzi","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0130","series-title":"One in 31: The Long Reach of American Corrections","year":"2009"},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0135","doi-asserted-by":"crossref","DOI":"10.1037\/adb0000090","article-title":"Predictors of patient retention in methadone maintenance treatment","author":"Proctor","year":"2015","journal-title":"Psychol. Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jsat.2006.03.003","article-title":"Predicting DSM-IV dependence diagnoses from Addiction Severity Index composite scores","volume":"31","author":"Rikoon","year":"2006","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0145","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/ajad.12286","article-title":"Anxiety, mood disorders and injection risk behaviors among cocaine users: results from the COSMO study","volume":"24","author":"Roy","year":"2015","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0150","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption\u2014II","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0155","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0924-9338(97)83297-X","article-title":"Reliability and validity of the MINI International Neuropsychiatric Interview (M.I.N.I.): according to the SCID-P","volume":"12","author":"Sheehan","year":"1997","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0160","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0165","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1017\/S146114570700836X","article-title":"Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study","volume":"11","author":"Soyka","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0170","doi-asserted-by":"crossref","first-page":"e7558","DOI":"10.1371\/journal.pone.0007558","article-title":"HIV\/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity","volume":"4","author":"Spaulding","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0175","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1360-0443.2009.02893.x","article-title":"Commentary on Larney (2010): a call to action\u2014opioid substitution therapy as a conduit to routine care and primary prevention of HIV transmission among opioid-dependent prisoners","volume":"105","author":"Springer","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cct.2013.12.006","article-title":"Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community","volume":"37","author":"Springer","year":"2014","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0190","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/00952990.2010.540280","article-title":"HIV, alcohol dependence, and the criminal justice system: a review and call for evidence-based treatment for released prisoners","volume":"37","author":"Springer","year":"2011","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"4","key":"10.1016\/j.drugalcdep.2015.10.023_bib0195","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s11524-010-9438-4","article-title":"Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment","volume":"87","author":"Springer","year":"2010","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0200","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1086\/421392","article-title":"Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community","volume":"38","author":"Springer","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0205","doi-asserted-by":"crossref","first-page":"e38335","DOI":"10.1371\/journal.pone.0038335","article-title":"Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners","volume":"7","author":"Springer","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0210","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/cid\/cir446","article-title":"Public health implications for adequate transitional care for HIV-infected prisoners: five essential components","volume":"53","author":"Springer","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0215","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1525-1497.2005.0228.x","article-title":"Buprenorphine retention in primary care","volume":"20","author":"Stein","year":"2005","journal-title":"J. Gen. Intern. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2015.10.023_bib0220","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1097\/QAI.0b013e3182097576","article-title":"The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine\/naloxone","volume":"56","author":"Sullivan","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0225","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1521-0391.2009.00003.x","article-title":"The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine\/naloxone for the treatment of opioid dependence","volume":"19","author":"Sullivan","year":"2010","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0230","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.15288\/jsad.2011.72.1012","article-title":"Adherence monitoring in naltrexone pharmacotherapy trials: a systematic review","volume":"72","author":"Swift","year":"2011","journal-title":"J. Stud. Alcohol Drugs"},{"key":"10.1016\/j.drugalcdep.2015.10.023_bib0235","series-title":"Joint Position Paper on Substitution Maintenance Therapy in the Management of Opioid Dependence and HIV\/AIDS Prevention","year":"2004"}],"updated-by":[{"DOI":"10.1016\/j.drugalcdep.2016.02.009","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000}}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871615017196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871615017196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T23:23:59Z","timestamp":1537226639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871615017196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":46,"alternative-id":["S0376871615017196"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.10.023","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.drugalcdep.2016.02.009","asserted-by":"object"}]},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}